Paradigm Asset Management Co. LLC lessened its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.5% in the 4th quarter, HoldingsChannel reports. The fund owned 47,108 shares of the biopharmaceutical company’s stock after selling 1,200 shares during the period. Bristol-Myers Squibb makes up about 0.6% of Paradigm Asset Management Co. LLC’s portfolio, […]
Paradigm Asset Management Co. LLC decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,300 shares of the medical research company’s stock after selling 200 shares […]
Paradigm Asset Management Co. LLC lessened its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 47,108 shares of the biopharmaceutical company’s stock after selling 1,200 shares during the period. Bristol-Myers Squibb makes up approximately 0.6% […]
Paradigm Asset Management Co. LLC cut its holdings in shares of AT&T Inc. (NYSE:T – Free Report) by 2.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 88,580 shares of the technology company’s stock after selling 2,600 shares during the period. Paradigm Asset […]
Paradigm Asset Management Co. LLC cut its stake in Merck & Co., Inc. (NYSE:MRK – Free Report) by 2.4% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 20,388 shares of the company’s stock after selling 500 shares during the quarter. Merck & Co., Inc. comprises 0.6% of Paradigm Asset Management Co. LLC’s holdings, […]